A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
Abstract Current SARS-CoV-2 vaccines are effective, but long-term protection is threatened by the emergence of virus variants. We generated a virosome vaccine containing the Beta spike protein and compared its immunogenicity in mice to a virosome vaccine containing the original Wuhan spike. Two admi...
Main Authors: | Yme U. van der Velden, Marloes Grobben, Tom G. Caniels, Judith A. Burger, Meliawati Poniman, Melissa Oomen, Esther Siteur-van Rijnstra, Khadija Tejjani, Denise Guerra, Ronald Kempers, Toon Stegmann, Marit J. van Gils, Rogier W. Sanders |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-07590-w |
Similar Items
-
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
by: Mitch Brinkkemper, et al.
Published: (2021-12-01) -
Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
by: Mitch Brinkkemper, et al.
Published: (2022-12-01) -
Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate
by: Bárbara Fernandes, et al.
Published: (2022-04-01) -
Diverse HIV-1 escape pathways from broadly neutralizing antibody PGDM1400 in humanized mice
by: Yme U. van der Velden, et al.
Published: (2020-01-01) -
Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice.
by: Tobias Kamphuis, et al.
Published: (2012-01-01)